Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5185516
Max Phase: Preclinical
Molecular Formula: C44H69N11O11S2
Molecular Weight: 992.24
Associated Items:
ID: ALA5185516
Max Phase: Preclinical
Molecular Formula: C44H69N11O11S2
Molecular Weight: 992.24
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2)CSCC(=O)CSC[C@@H](C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C44H69N11O11S2/c1-23(2)16-31-39(61)49-25(5)36(58)50-30(9-7-15-48-44(45)46)38(60)55-35(43(65)66)22-68-20-28(57)19-67-21-34(54-37(59)29-8-6-14-47-29)42(64)52-32(17-24(3)4)40(62)53-33(41(63)51-31)18-26-10-12-27(56)13-11-26/h10-13,23-25,29-35,47,56H,6-9,14-22H2,1-5H3,(H,49,61)(H,50,58)(H,51,63)(H,52,64)(H,53,62)(H,54,59)(H,55,60)(H,65,66)(H4,45,46,48)/t25-,29-,30-,31-,32-,33-,34-,35-/m0/s1
Standard InChI Key: JIBAUMAHVNYSFI-LEZLZINTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 992.24 | Molecular Weight (Monoisotopic): 991.4619 | AlogP: -1.41 | #Rotatable Bonds: 13 |
Polar Surface Area: 352.23 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.77 | CX Basic pKa: 13.51 | CX LogP: -3.46 | CX LogD: -4.78 |
Aromatic Rings: 1 | Heavy Atoms: 68 | QED Weighted: 0.06 | Np Likeness Score: 0.66 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):